These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves. Maegdefessel L, Linde T, Krapiec F, Hamilton K, Steinseifer U, van Ryn J, Raaz U, Buerke M, Werdan K, Schlitt A. Thromb Res; 2010 Sep; 126(3):e196-200. PubMed ID: 20659761 [Abstract] [Full Text] [Related]
24. [Low-molecular-weight heparin in the prevention of thromboembolism in pregnant thrombophilic patients]. Boda Z, László P, Rejtö L, Tornai I, Pfliegler G, Rák K. Orv Hetil; 1996 Jan 28; 137(4):183-5. PubMed ID: 8721833 [Abstract] [Full Text] [Related]
26. Anticoagulation for mechanical heart valves during pregnancy: A case report and a literature review. Bai C, Wu H, Wu W, Feng P, Nie M, Zhao L, Meng F. Medicine (Baltimore); 2022 Dec 30; 101(52):e32550. PubMed ID: 36596070 [Abstract] [Full Text] [Related]
28. Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: what are the risks? A retrospective observational study. Basude S, Hein C, Curtis SL, Clark A, Trinder J. BJOG; 2012 Jul 30; 119(8):1008-13; discussion 1012-3. PubMed ID: 22568528 [Abstract] [Full Text] [Related]
37. Audit of the peri-delivery use of unfractionated heparin in women on therapeutic low-molecular weight heparin. Lambert JR, Austin SK, Peebles D, Cohen H. Br J Haematol; 2008 Jul 30; 142(3):453-6. PubMed ID: 18510687 [Abstract] [Full Text] [Related]